BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 29, 2026
Home
»
Newsletters
» BioWorld
BioWorld
June 15, 2004
View Archived Issues
Vertex's Deal With Mitsubishi: $33M To Boost HCV Research
Read More
Idun Placement Gets $27M To Progress Liver Therapy
Read More
Alexion, P&G Get FDA Clearance On Pexelizumab Phase III Design
Read More
Theravance Registers For $96M IPO To Advance Drug Programs
Read More
OSI Reports Anticipated Negative Results In Aptosyn Phase III Trial
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
QLT, Atrix Merging In $855M Deal To Grow Pipeline, Build Business
In a transaction valued at $855 million, QLT Inc. and Atrix Laboratories Inc. are merging into a single entity with two marketed products and a multitude of pipeline possibilities. (BioWorld Today)
Read More
